Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 13 of 13

List	Outcome	Time frame
Primary	Rate of sustained MRD negativity (NGS, 10^-5)	38 months
Primary	Rate of conversion from positive MRD to negative MRD (NGS, 10^-5)	38 months
Secondary	Number of adverse events	50 months
Secondary	Rate of sustained MRD negativity (NGS, 10^-6)	38 months
Secondary	Rate of conversion from positive MRD to negative MRD (NGS, 10^-6).	38 months
Secondary	Rate of conversion from positive MRD to negative MRD (NGS, 10^-5).	23 months
Secondary	Number of the death	74 months
Secondary	Number of responses	50 months
Secondary	Number of progression-free survival	74 months
Secondary	Percentage of duration of response	74 months
Secondary	Percenatge of time to response	74 months
Other	Percentage of value of biological prognostic factors influencing outcome and response.	38 months
Other	Percentage of score of quality of life	38 months

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06353022/registered